MediWound (NASDAQ:MDWD – Get Rating) released its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.01), MarketWatch Earnings reports. MediWound had a negative return on equity of 3,540.43% and a negative net margin of 57.03%. During the same quarter in the prior year, the business posted ($0.10) EPS.
Shares of NASDAQ:MDWD opened at $1.77 on Wednesday. MediWound has a twelve month low of $1.25 and a twelve month high of $6.22. The stock’s 50 day moving average is $2.01 and its 200-day moving average is $2.39.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Wells Fargo & Company MN lifted its stake in shares of MediWound by 12.3% in the fourth quarter. Wells Fargo & Company MN now owns 322,677 shares of the biopharmaceutical company’s stock valued at $762,000 after buying an additional 35,238 shares in the last quarter. Millennium Management LLC bought a new position in MediWound in the 4th quarter valued at about $57,000. Jane Street Group LLC acquired a new position in MediWound during the 3rd quarter valued at about $38,000. Morgan Stanley increased its holdings in MediWound by 12.4% during the 3rd quarter. Morgan Stanley now owns 85,947 shares of the biopharmaceutical company’s stock worth $287,000 after purchasing an additional 9,497 shares in the last quarter. Finally, Goldman Sachs Group Inc. purchased a new stake in shares of MediWound in the third quarter worth approximately $48,000. 13.58% of the stock is owned by institutional investors and hedge funds.
About MediWound (Get Rating)
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.
- Get a free copy of the StockNews.com research report on MediWound (MDWD)
- The Weber, Inc Growth Story Goes Up In Smoke
- Roku Stock is Repricing and Resetting Itself
- The Institutions Are Capping Gains In Take-Two Interactive
- Walmart’s “Everyday Low Prices” Gets Burned By Inflation
- VMWare Inc: Strong Revenues and Excellent Potential
Receive News & Ratings for MediWound Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediWound and related companies with MarketBeat.com's FREE daily email newsletter.